News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Snyder Mark Howard
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/21/2023 |
4
| Snyder Mark Howard (SVP, GENERAL COUNSEL) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns:
| Granted 54,955 options to buy
@ $49.26, valued at
$2.7M
Granted 19,184 restricted stock units
@ $0 |
|
01/04/2023 |
4
| Snyder Mark Howard (SVP, GENERAL COUNSEL) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns:
| Paid exercise price by delivering 2,804 shares
@ $55.13, valued at
$154.6k
Exercised 7,611 restricted stock units
@ $0 |
|
01/05/2022 |
4
| Snyder Mark Howard (SVP, General Counsel) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns:
| Granted 83,142 options to buy
@ $41.06, valued at
$3.4M
Granted 30,444 restricted stock units
@ $0 |
|
01/05/2022 |
3
| Snyder Mark Howard (SVP, General Counsel) has filed a Form 3 on HALOZYME THERAPEUTICS, INC. |
|
|